EYAL MUSCAL to Anti-N-Methyl-D-Aspartate Receptor Encephalitis
This is a "connection" page, showing publications EYAL MUSCAL has written about Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Connection Strength
1.600
-
Differences in treatment of anti-NMDA receptor encephalitis: results of a worldwide survey. J Neurol. 2017 Apr; 264(4):647-653.
Score: 0.534
-
Isolated Psychiatric Symptoms in Children With Anti-N-Methyl-d Aspartate Receptor Encephalitis. Pediatr Neurol. 2024 Oct; 159:12-15.
Score: 0.224
-
Arterial Spin Labeling Changes Parallel Asymmetric Perisylvian and Perirolandic Symptoms in 3 Pediatric Cases of Anti-NMDAR Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2023 07; 10(4).
Score: 0.206
-
Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis. JAMA Neurol. 2021 11 01; 78(11):1333-1344.
Score: 0.186
-
International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2021 07; 8(5).
Score: 0.182
-
Infectious and Autoimmune Causes of Encephalitis in Children. Pediatrics. 2020 06; 145(6).
Score: 0.167
-
The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord. 2013 Apr; 28(4):543-7.
Score: 0.101